Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Raphael E Szalat, M.D.

Concepts (221)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Raphael Szalat's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Raphael Szalat has written about over time.
Antigens, Nuclear, 1 publications between 2010 and 2010, average publication date May 2010. Nuclear Matrix-Associated Proteins, 1 publications between 2010 and 2010, average publication date May 2010. Xanthomatosis, 1 publications between 2011 and 2011, average publication date July 2011. Cryoglobulinemia, 3 publications between 2012 and 2016, average publication date September 2014. Paraproteinemias, 7 publications between 2011 and 2022, average publication date July 2015. Immunoglobulin A, 1 publications between 2015 and 2015, average publication date September 2015. Immunoglobulin Isotypes, 1 publications between 2015 and 2015, average publication date September 2015. Necrobiotic Xanthogranuloma, 3 publications between 2014 and 2017, average publication date October 2015. Emergencies, 1 publications between 2017 and 2017, average publication date September 2017. Hematologic Diseases, 1 publications between 2017 and 2017, average publication date September 2017. Hemolysis, 1 publications between 2017 and 2017, average publication date September 2017. Gene Expression Regulation, Neoplastic, 6 publications between 2016 and 2019, average publication date April 2018. DNA Repair, 2 publications between 2017 and 2019, average publication date July 2018. Waldenstrom Macroglobulinemia, 4 publications between 2014 and 2023, average publication date November 2018. Multiple Myeloma, 24 publications between 2013 and 2024, average publication date April 2019. Antineoplastic Agents, Alkylating, 1 publications between 2020 and 2020, average publication date July 2020. Melphalan, 3 publications between 2020 and 2023, average publication date February 2022. Amyloidosis, 3 publications between 2022 and 2023, average publication date November 2022.

To see the data from this visualization as text, click here.
Szalat's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (221)
Explore
_
Co-Authors (33)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.